Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers

Oncogene volume 22, pages 2897–2909 (2003)Cite this article

Abstract

Our group recently identified Ras homolog member I (ARHI), a novel maternally imprinted tumor suppressor gene that encodes a 26 kDa GTP-binding protein with high homology to Ras and Rap. Unlike other Ras family members, ARHI exhibits several unusual structural and functional properties. ARHI contains a unique 34 amino-acid extension at the N-terminus, and differs from Ras in residues critical for GTPase activity and in its putative effector domain. Like Ras, ARHI can bind to GTP with high affinity but has low intrinsic GTPase activity. In addition, while Ras is an oncogene, ARHI functions as an inhibitor for cell growth. 32Phosphorus labeling showed that ARHI is maintained in a constitutively activated GTP-bound state in resting cells, possibly because of impaired GTPase activity. ARHI is associated at the cell membrane through its prenylation at the C-terminal cysteine residue. Mutation of the conserved CAAX box at the C-terminus led to a loss of its membrane association and a decreased ability to inhibit cell growth. Conversion of Ser51 to Asn decreased GTP binding and reduced ARHI's biological activity. Mutation of Ala46 to Val increased the ability of ARHI to inhibit cell growth, associated with a further decrease of its intrinsic GTPase activity. Moreover, conversion of residues in ARHI that are conserved in the Ras family for GTPase activity partially restored the GTPase activity in ARHI. Most strikingly, deletion of ARHI's unique N-terminal extension nearly abolished its inhibitory effect on cell growth, suggesting its importance in ARHI's inhibitory function. Thus, ARHI is a unique Ras family member that retains basic small GTPase function, but exhibits many unusual features. In contrast to most other Ras family members, ARHI has a long N-terminal extension, modest GTPase activity, and constitutive GTP binding in resting cells. Furthermore, unlike the Ras oncogene, ARHI inhibits cell growth, and loss of its expression in cells may contribute to the development of breast and ovarian cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Ashar HR, James L, Gray K, Carr D, Black S, Armstrong L, Bishop WR and Kirschmeier P . (2000). J. Biol. Chem., 275, 30451–30457.

  • Bhullar RP and Haslam RJ . (1987). Biochem. J., 245, 617–620.

  • Boguski MS and McCormick F . (1993). Nature, 366, 634–654.

  • Bollag G and McCormick F . (1995). Methods Enzymol., 225, 161–181.

  • Bounre HR, Sanders DA and McCormick F . (1991). Nature, 349, 117–127.

  • Chen JM, Manolatos S, Brandt-Rauf PW, Murphy RB, Monaco R and Pincus MR . (1996). J. Protein Chem., 15, 511–518.

  • Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, Ivanov IE and Philips MR . (1999). Cell, 98, 69–80.

  • Clark GJ and Der CJ . (1995). Breast Cancer Res. Treat., 35, 133–144.

  • Der C, Finkel T and Cooper GM . (1986). Cell, 44, 167–176.

  • Downward J . (1992). Bioessays, 14, 177–184.

  • Ellis CA, Vos MD, Howell H, Vallecorsa T, Fults DW and Clark GJ . (2002). Proc. Natl. Acad. Sci. USA, 99, 9876–9881.

  • Fiegen D, Blumenstein L, Stege P, Vetter IR and Ahmadian MR . (2002). FEBS Lett., 525, 100–104.

  • Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA and Perou CM . (2001). J. Biol. Chem., 276, 42259–42267.

  • Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J and Settleman J . (1996). Mol. Cell Biol., 16, 2689–2699.

  • Garavini H, Riento K, Phelan JP, McAlister MS, Ridley AJ and Keep NH . (2002). Biochemistry, 41, 6303–6310.

  • Gotoh T, Cai D, Tian X, Feig LA and Lerner A . (2000). J. Biol. Chem., 275, 301118–301123.

  • Hall A and Self AJ (1986). J. Biol. Chem., 261, 10963–10996.

  • Hofemeister H, Weber K and Stick R . (2000). Mol. Biol. Cell, 11, 3233–3246.

  • Lowy DR and Willumsen BM (1993). Annu. Rev. Biochem., 62, 851–891.

  • Luo RZ, Peng HQ, Xu FJ, Bao JJ, Pang Y, Pershad R, Issa J-P J, Liao WS-L, Bast Jr RC and Yu Y . (2001). Biochem. Biophys. Acta, 1519, 216–222.

  • Maguire J, Santoro T, Jensen P, Siebenlist U, Yewdell J and Kelly K . (1994). Science, 265, 241–244.

  • McGrath JP, Capon DJ, Goeddel DV and Levinson AD . (1984). Nature, 310, 644–649.

  • Muller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R and Schul R . (2002). EMBO J., 21, 736–748.

  • Murphy GA, Solski PA, Jillian SA, Perez de la Ossa P, D'Eustachio P, Der CJ and Rush MG . (1999). Oncogene, 18, 3831–3845.

  • Nassar N, Horn G, Herrmann C, Scherer A, McCormick F and Wittinghofe RA . (1995). Nature, 375, 554–560.

  • Nobes CD, Lauritzen I, Mattel MG, Paris S, Hall A and Chardin P . (1998) J. Cell Biol., 141, 187–197.

  • Park HO, Chant J and Herskowitz I . (1993). Nature, 365, 269–274.

  • Patton SE, Martin ML, Nelsen LL, Fang X, Mills GB, Bast Jr RC and Ostrowski MC . (1998). Cancer Res., 58, 2253–2259.

  • Peng HQ, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast Jr RC and Yu Y . (2000). Int. J. Cancer, 86, 690–694.

  • Piddini E, Schmid JA, de Martin R and Dotti CG . (2001). EMBO J., 20, 4076–4087.

  • Reuther GW and Der CJ . (2000). Curr. Opin. Cell Biol., 12, 157–165.

  • Ridley AJ and Hall A . (1992). Cell, 70, 389–399.

  • Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J . (1994). Nature, 370, 508–509.

  • Seeburg PH, Colby WW, Capon DJ, Goeddel DV and Levinson AD . (1984). Nature, 312, 71–75.

  • Sunyer T, Codina J and Birnbaumer L . (1984). J. Biol. Chem., 259, 15447–15451.

  • Tisdale EJ, Bourne JR, Khosravi-Far R, Channing JD and Balch WE . (1992). J. Cell Biol., 119, 749–761.

  • Willumsen BM, Papageorge AG, Kung HF, Bekesi E, Robins T, Johnsen M, Vass WC and Lowy DR . (1986). Mol. Cell Biol., 6, 2646–2654.

  • Xu F, Xia W, Luo RZ, Peng H, Zhao S, Dai J, Long Y, Zhao L, Le W, Parlow AF, Hung MC, Bast Jr RC and Yu, Y . (2000). Cancer Res., 60, 4913–4920.

  • Yu Y, Xu F, Peng HQ, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB and Bast Jr RC . (1999). Proc. Natl. Acad. Sci. USA, 96, 214–219.

  • Zheng Y, Hart MJ and Cerione RA (1995). Methods Enzymol., 256, 77–84.

  • Zhu J, Reynet C, Caldwell JS and Kahn CR . (1995). J. Biol. Chem., 270, 4805–4812.

Download references

Acknowledgements

This work was supported in part by National Institutes of Health Grants CA64602 (to RCB) and CA80957 (to YY); a Susan G Komen Breast Cancer Foundation Grant (to YY); and an MD Anderson Institutional Foundation Grant (to RZL).

Author information

Authors and Affiliations

  1. Department of Experimental Therapeutics, The University of Texas,MD Anderson Cancer Center, Houston, 77030, TX, USA

    Robert Z Luo, Rebecca Marquez, Yinhua Yu & Robert C Bast Jr

  2. Department of Molecular Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, 77030, TX, USA

    Xianjun Fang, Shu-Ying Liu & Gordon B Mills

  3. Department of Biochemistry and Molecular Biology, The University of Texas, MD Anderson Cancer Center, Houston, 77030, TX, USA

    Warren S-L Liao

Authors
  1. Robert Z Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xianjun Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebecca Marquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shu-Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gordon B Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Warren S-L Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yinhua Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert C Bast Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert C Bast Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luo, R., Fang, X., Marquez, R. et al. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 22, 2897–2909 (2003). https://doi.org/10.1038/sj.onc.1206380

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206380

Keywords

This article is cited by

Search

Advanced search

Quick links